Skip to main content
. 2008 Apr 18;74(12):3672–3681. doi: 10.1128/AEM.02624-07

TABLE 3.

Phenotypic resistance of commensal E. coli isolates sampled across human vocation groupsa

Antimicrobial No. of E. coli isolates sampled by human vocation group (% of total)
P valueb
Non-swine workers/ nonconsumers (n = 528) Swine workers (n = 1,131) Non-swine workers (n = 1,675) Slaughter plant workers (n = 307) Influent (mixed isolates) (n = 252)
Amikacin 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0) 0 (0.0) 0.497
Amoxicillin-clavulanic acid 29 (5.5) 22 (2.0) 41 (2.5) 12 (3.9) 5 (2.0) 0.002
Ampicillin 135 (25.6) 152 (13.4) 245 (14.6) 49 (16.0) 42 (16.7) <0.001
Cefoxitin 34 (6.4) 17 (1.5) 45 (2.7) 16 (5.2) 6 (2.4) <0.001
Ceftiofur 0 (0.0) 4 (0.4) 7 (0.4) 3 (1.0) 0 (0.0) 0.497
Ceftriaxone 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0) 0 (0.0) 0.092
Chloramphenicol 9 (1.7) 24 (2.1) 27 (1.6) 2 (0.7) 2 (0.8) 0.258
Ciprofloxacin 10 (1.9) 8 (0.7) 13 (0.8) 0 (0.0) 0 (0.0) 0.005
Gentamicin 0 (0.0) 6 (0.5) 9 (0.5) 5 (1.6) 0 (0.0) 0.012
Kanamycin 16 (3.0) 12 (1.1) 20 (1.2) 11 (3.6) 0 (0.0) <0.001
Nalidixic acid 24 (4.6) 54 (4.8) 94 (5.6) 1 (0.3) 14 (5.6) <0.001
Streptomycin 55 (10.4) 100 (8.8) 141 (8.4) 38 (12.4) 25 (9.9) 0.209
Sulfisoxazole 67 (12.7) 114 (10.1) 224 (13.4) 42 (13.7) 31 (12.3) 0.099
Tetracycline 98 (18.6) 231 (20.4) 300 (18.0) 102 (33.2) 57 (22.6) <0.001
Trimethoprim-sulfamethoxazole 45 (8.5) 74 (6.5) 125 (7.5) 33 (10.8) 13 (5.2) 0.069
a

Phenotypic resistance of commensal E. coli isolates from human wastewater samples (n = 3,893 isolates, with vocation cohorts identified). Frequencies and proportions are contrasted with human vocation cohorts across all unit locations and seasons.

b

P values are based on a likelihood ratio chi-square test of the differences in risk between human vocation cohorts. These P values are not adjusted for the dependence of responses within unit locations.